The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections
Authors:
Open Access
- 14 February 2019
- journal article
- review article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 126 (3) , 265-278
Abstract
Cardiovascular (CV) diseases and mood disorders are common public health problems worldwide. Their connections are widely studied, and the role of neurotrophins (NTs) is already supposed in both conditions. However, data in the literature of clinical aspects are sometimes controversial and no reviews are available describing possible associations between CV risk and mood disorders based on NTs. The mostly studied NT is brain-derived neurotrophic factor (BDNF). Decreased level of BDNF is observed in depression and its connection to hypertension has also been demonstrated with affecting the arterial baroreceptors, renin–angiotensin system and endothelial nitric oxide synthase. BDNF was also found to be the predictor of CV outcome in different patient populations. Other types of human NT-s, such as nerve growth factor, neurotrophin 3 and neurotrophin 4 also seem to have both psychopathological and CV connections. Our aim was to overview the present knowledge in this area, demonstrating a new aspect of the associations between mood disorders and CV diseases through the mediation of NTs. These findings might enlighten new psychosomatic connections and suggest new therapeutic targets that are beneficial both in respect of mood disorders and CV pathology.Keywords
Funding Information
- National Research, Development and Innovation Office (NN-11460, K112629, FK124491, K116928)
- Hungarian Academy of Sciences (VKE-2017-00006)
- Ministry of Human Capacities, State Secretary for Education (EEMOFAKT-2017)
- Hungarian Academy of Sciences - Semmelweis University Lend?let Research Grant (LP008/2017)
This publication has 172 references indexed in Scilit:
- Neurobiology of Major Depressive DisorderNeural Plasticity, 2013
- Neurohumoral StimulationHeart Failure Clinics, 2012
- Neuronal Brain-derived Neurotrophic Factor Is Synthesized in Excess, with Levels Regulated by Sortilin-mediated Trafficking and Lysosomal DegradationJournal of Biological Chemistry, 2011
- Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatmentMolecular Psychiatry, 2010
- Neurotrophin-3 Is a Novel Angiogenic Factor Capable of Therapeutic Neovascularization in a Mouse Model of Limb IschemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depressionJournal of Affective Disorders, 2009
- Brain‐derived neurotrophic factor in arterial baroreceptor pathways: implications for activity‐dependent plasticity at baroafferent synapsesJournal of Neurochemistry, 2008
- Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and ImplicationsBiological Psychiatry, 2008
- BDNF: A key regulator for protein synthesis-dependent LTP and long-term memory?Neurobiology of Learning and Memory, 2008
- Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promotersGenomics, 2007